299 related articles for article (PubMed ID: 25387618)
21. [An investigation on correlation of severity of brain injury with the expression of activin A and C-reactive protein].
Sun RQ; Shi XY; Yang HF; Hao QM; Zhu LC; Liu QL; Niu JJ
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):681-5. PubMed ID: 24225214
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of neuron-specific enolase in head trauma patients.
Meric E; Gunduz A; Turedi S; Cakir E; Yandi M
J Emerg Med; 2010 Apr; 38(3):297-301. PubMed ID: 18499387
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS).
Şirinoğlu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Yalındağ-Öztürk N; Cinel İ; Yaman A; Haklar G; Şirikci Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
J Infect Chemother; 2017 Jan; 23(1):17-22. PubMed ID: 27771157
[TBL] [Abstract][Full Text] [Related]
24. Association of the Circulating Supar Levels with Inflammation, Fibrinolysis, and Outcome in Severe Burn Patients.
Lin JC; Chen XD; Xu ZR; Zheng LW; Chen ZH
Shock; 2021 Dec; 56(6):948-955. PubMed ID: 34779798
[TBL] [Abstract][Full Text] [Related]
25. Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - Progress in prediction of AP severity.
Lipinski M; Rydzewska-Rosolowska A; Rydzewski A; Cicha M; Rydzewska G
Pancreatology; 2017; 17(1):24-29. PubMed ID: 27914940
[TBL] [Abstract][Full Text] [Related]
26. Serum soluble urokinase plasminogen activator receptor in alcoholics: relation to liver disease severity, fibrogenesis, and alcohol use.
Tuomi H; Kultti J; Danielsson J; Kangastupa P; Akerman K; Niemelä O
J Gastroenterol Hepatol; 2014 Dec; 29(12):1991-5. PubMed ID: 24909734
[TBL] [Abstract][Full Text] [Related]
27. The inflammatory marker suPAR after cardiac arrest.
Rundgren M; Lyngbaek S; Fisker H; Friberg H
Ther Hypothermia Temp Manag; 2015 Jun; 5(2):89-94. PubMed ID: 25695339
[TBL] [Abstract][Full Text] [Related]
28. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
[TBL] [Abstract][Full Text] [Related]
29. Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients.
Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Serrano N; Rodríguez ST; Jiménez A; Borreguero-León JM
Thromb Res; 2014 Oct; 134(4):832-6. PubMed ID: 25123332
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients.
Lomholt AF; Christensen IJ; Høyer-Hansen G; Nielsen HJ
Acta Oncol; 2010 Aug; 49(6):805-11. PubMed ID: 20524776
[TBL] [Abstract][Full Text] [Related]
31. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
32. The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer.
Wach S; Al-Janabi O; Weigelt K; Fischer K; Greither T; Marcou M; Theil G; Nolte E; Holzhausen HJ; Stöhr R; Huppert V; Hartmann A; Fornara P; Wullich B; Taubert H
Int J Cancer; 2015 Sep; 137(6):1406-16. PubMed ID: 25754273
[TBL] [Abstract][Full Text] [Related]
33. Significance of troponin elevation after severe traumatic brain injury.
Salim A; Hadjizacharia P; Brown C; Inaba K; Teixeira PG; Chan L; Rhee P; Demetriades D
J Trauma; 2008 Jan; 64(1):46-52. PubMed ID: 18188098
[TBL] [Abstract][Full Text] [Related]
34. Increased plasma 8-iso-prostaglandin F2α concentration in severe human traumatic brain injury.
Yu GF; Jie YQ; Wu A; Huang Q; Dai WM; Fan XF
Clin Chim Acta; 2013 Jun; 421():7-11. PubMed ID: 23466601
[TBL] [Abstract][Full Text] [Related]
35. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of the abbreviated injury score and the injury severity score in comparison to the Glasgow Coma Scale in predicting outcome after traumatic brain injury.
Foreman BP; Caesar RR; Parks J; Madden C; Gentilello LM; Shafi S; Carlile MC; Harper CR; Diaz-Arrastia RR
J Trauma; 2007 Apr; 62(4):946-50. PubMed ID: 17426553
[TBL] [Abstract][Full Text] [Related]
37. Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males.
da Rocha AB; Zanoni C; de Freitas GR; André C; Himelfarb S; Schneider RF; Grivicich I; Borges L; Schwartsmann G; Kaufmann M; Regner A
J Neurotrauma; 2005 Sep; 22(9):966-77. PubMed ID: 16156712
[TBL] [Abstract][Full Text] [Related]
38. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
Eugen-Olsen J; Andersen O; Linneberg A; Ladelund S; Hansen TW; Langkilde A; Petersen J; Pielak T; Møller LN; Jeppesen J; Lyngbaek S; Fenger M; Olsen MH; Hildebrandt PR; Borch-Johnsen K; Jørgensen T; Haugaard SB
J Intern Med; 2010 Sep; 268(3):296-308. PubMed ID: 20561148
[TBL] [Abstract][Full Text] [Related]
39. Decreased plasma gelsolin is associated with 1-year outcome in patients with traumatic brain injury.
Jin Y; Li BY; Qiu LL; Ling YR; Bai ZQ
J Crit Care; 2012 Oct; 27(5):527.e1-6. PubMed ID: 22386223
[TBL] [Abstract][Full Text] [Related]
40. The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis.
Huang F; Li Y; Xu R; Cheng A; Lv Y; Liu Q
Mediators Inflamm; 2020; 2020():7850179. PubMed ID: 32322165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
